Security key
74019P108
- Security type / class
- Equity / COM
- Total 13F shares
- 51,658,381
- Total 13F value
- $67,159,246
- Share change
- -6,606,774
- Put/Call ratio
- 23%
- SEC-reported price per share
- $1.30
- Number of holders
- 89
- Value change
- -$11,690,977
- Number of buys
- 42
- Number of sells
- 51
Open additional details 1 more signal available
Report period
Q3 2022
Institutions
89
Top holders
10
DTIL full security history
Ownership snapshot
Full 13F holder table
PRECISION BIOSCIENCES INC SEC filings
PRECISION BIOSCIENCES INC company facts
Broader feeds
Ownership snapshot
Top reported holders of DTIL - PRECISION BIOSCIENCES INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
NOVARTIS PHARMA AG
Disclosed value leader
Capital World Investors
Comparable rows
0/15
Latest evidence
30 Jun 2022
3/4/5
13F
Highest disclosed value: $10,744,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Capital World Investors has the largest disclosed position value at $10.74M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Capital World Investors's linked filing trail.
Disclosed position value
Top 5
NOVARTIS PHARMA AG
$4.59M
Capital World Investors
$10.74M
GREAT POINT PARTNERS LLC
$9.21M
EcoR1 Capital, LLC
$8.06M
CVI Holdings, LLC
$6.8M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| NOVARTIS PHARMA AG |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$4,590,753
12,407,440 shares
|
— | 15 Jun 2022 |
| Capital World Investors |
13F
Company
|
—
denominator unverified
|
$10,744,000
6,715,043 shares
|
— | 30 Jun 2022 |
| GREAT POINT PARTNERS LLC |
13F
Company
|
—
denominator unverified
|
$9,209,000
5,755,396 shares
|
— | 30 Jun 2022 |
| EcoR1 Capital, LLC |
13F
Company
|
—
denominator unverified
|
$8,058,000
5,035,971 shares
|
— | 30 Jun 2022 |
| CVI Holdings, LLC |
13F
Company
|
—
denominator unverified
|
$6,802,000
4,251,490 shares
|
— | 30 Jun 2022 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$5,552,000
3,470,092 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
89
Shares
51,658,381
Rows available
89
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
104
Q3 2022 holders
89
Holder diff
-15
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|